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__________________________________ 
Introduction
 
ZD2767P  is  a  bis-iodo  phenol  mustard 
prodrug  used  in  a  two-step  approach  of 
targeting  chemotherapy  involving  either 
antibody-directed enzyme prodrug therapy 
(ADEPT)  or  gene-directed  enzyme 
prodrug therapy (GDEPT) [1]. 

ZD2767P  has  very  poor  stability  in 
aqueous  solution.  Therefore  the  existing 
method  for  ZD2767P  delivery  is  to 
provide  ZD2767P  as  a  powder,  with 
reconstitution in cold sodium bicarbonate 
solution immediately prior to intravenous 
administration through a Hickman line [2]. 

__________________________________
Materials and Methods 

ZD2767P was  supplied  by  AstraZeneca. 
For  HPLC  analysis  of  ZD2767P,  a 
Spherisorb  ODS  column  with  a  H2O/ 
acetonitrile  gradient  was  used.  Samples 
were diluted with NMP/H2O and analysed 
immediately  to  minimise  degradation. 
Microtitrimetry analysis was performed on 
a Sirius T3.

__________________________________ 
Results and Discussion 
 
Microtitrimetry  analysis  of  ZD2767P 
determined the following pKa values: 3.0 
(carboxyl),  3.6  (amine),  4.8  (carboxyl). 
This indicates that a pH > 4.8 is required 
for good solubility of ZD2767P. However, 
hydroxyl  ions  strongly  accelerate 
degradation  of  ZD2767P by nucleophilic 
substitution of the iodide in the molecule, 
as illustrated in the pH stability (Fig. 2). 
Hence,  careful  conversion  of  ZD2767P 
into  the  salt  form while  avoiding excess 
alkali is critical.

N-Methylpyrrolidone (NMP) emerged as a 
suitable solvent for formulation (Table 1) 
because  ZD2767P  shows  excellent 
solubility  as  well  as  comparably  good 
stability in this solvent. A high solubility is 
critical because relatively large amounts of 
ZD2767P (610mg) are administered.



 
 
__________________________________ 
Results and Discussion (continued) 
  
An  alternative  method  for  reconstitution 
was  developed  whereby  ZD2767P  is 
dissolved in NMP (305 mg/ml), followed 
by addition of 8.4%w/v NaHCO3 solution. 
The molar  ratio  of  NaHCO3:ZD2767P is 
1.6.  After  the  initial  burst  of  CO2  the 
solution is diluted with saline to adjust the 
NMP  content  to  20%v/v.  ZD2767P 
reconstituted with the ÔnewÕ method shows 
improved stability (Table 2).

Advantages of dissolution in NMP are: i) 
no frothing which spreads ZD2767P over 
the  surface  of  the  vial  (as  occurs  when 
dissolved  directly  in  NaHCO3)  and  ii) 
dissolution  time  and  temperature  are  not 
critical  because  ZD2767P is  comparably 
stable  in  NMP at  RT.  Overall,  the  Ônew 
methodÕ is  a clean process because there 
are no solids present during the initial CO2 
burst following NaHCO3 addition.

________________________________ 
Conclusion 
 
An alternative method for reconstitution of 
ZD2767P  has  been  developed  which 
provides improved handling characteristics 
and  room  temperature  stability  where 
previously cold temperature manipulation 
and  storage  was  required.  This  allows  a 
longer  time-window  between 
reconstitution and administration.
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Figure 1:  Structure of ZD2767P
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Figure 2:  pH stability of ZD2767P at RT
Solvent Solubility  
(mg/ml) 
Stability  
T1/10
* at RT 
NMP > 401 > 15 h 
Methanol > 64.7 ~8 min 
2-Propanol 11.6 - 15.4 18.2 h 
Butanol 16.5 - 22.0 3.1 h 
DMSO > 58.8 - 
8.4% w/v NaHCO3 > 49.2 - 
1M HCl 2.1 - 3.2 - 
5% v/v Acetic acid 1.2 - 1.4 - 
HPLC grade H2O ~0.4 - 
T1/10: time within which 10% of the initial ZD2767P degrades 
Table 1:  Solubility and stability of ZD2767P
Table 2: Comparison of reconstitution methods
Preparation Molar ratio 
NaHCO3/ 
ZD2767P 
NMP 
% 
Storage          
Temp. 
Stability 
T1/10
*  
(min) 
Existing 3 0 4¡C 211 
method  20¡C 53 
   20¡C 527 
New method 1.6 20 26-28¡C 151 
   40¡C 28 
T1/10: time within which 10% of the initial ZD2767P degrades 
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